HDAC6 and liver cancer: revealed that tubacin, an inhibitor of histone deacetylase 6 (HDAC6), in combination with docetaxel, could arrest the cell cycle, inhibit metastasis and proliferation, as well as induce apoptosis of liver cancer cells (231).